Experiment set5IT007 for Cupriavidus basilensis FW507-4G11

Compare to:

R2A with Lomefloxacin hydrochloride 0.00075 mM

Group: stress
Media: R2A + Lomefloxacin hydrochloride (0.000750 mM)
Culturing: cupriavidus_4G11_ML11, 24 deep-well microplate; Multitron, Aerobic, at 30 (C), shaken=750 rpm
Growth: about 3.5 generations
By: Mark on 05/13/2015
Media components: 0.5 g/L Bacto Peptone, 0.5 g/L casamino acids, 0.5 g/L Yeast Extract, 0.5 g/L D-Glucose, 0.5 g/L Starch, 0.3 g/L Potassium phosphate dibasic, 0.05 g/L Magnesium Sulfate Heptahydrate, 0.3 g/L Sodium pyruvate

Specific Phenotypes

For 53 genes in this experiment

For stress Lomefloxacin hydrochloride in Cupriavidus basilensis FW507-4G11

For stress Lomefloxacin hydrochloride across organisms

SEED Subsystems

Subsystem #Specific
Carotenoids 2
DNA-replication 2
DNA repair, bacterial 2
Glycerolipid and Glycerophospholipid Metabolism in Bacteria 2
Biflavanoid biosynthesis 1
DNA repair, bacterial RecFOR pathway 1
Folate Biosynthesis 1
Lipid A modifications 1
Multidrug Resistance Efflux Pumps 1
Multidrug efflux pump in Campylobacter jejuni (CmeABC operon) 1
Phosphate metabolism 1
Phosphonate metabolism 1
Tannin biosynthesis 1

Metabolic Maps

Color code by fitness: see overview map or list of maps.

Maps containing gene(s) with specific phenotypes:

MetaCyc Pathways

Pathways that contain genes with specific phenotypes:

Pathway #Steps #Present #Specific
2-aminoethylphosphonate biosynthesis 3 3 3
methylphosphonate biosynthesis 4 2 2
leucopelargonidin and leucocyanidin biosynthesis 4 2 2
palmitoleate biosynthesis III (cyanobacteria) 2 1 1
2-aminoethylphosphonate degradation II 2 1 1
phospholipid remodeling (phosphatidate, yeast) 2 1 1
diploterol biosynthesis 2 1 1
phosphatidylglycerol biosynthesis II 6 6 2
phosphatidylglycerol biosynthesis I 6 6 2
cardiolipin biosynthesis II 3 3 1
gentisate degradation I 3 3 1
oleate biosynthesis III (cyanobacteria) 3 2 1
cardiolipin biosynthesis III 3 2 1
2-aminoethylphosphonate degradation I 3 2 1
cardiolipin biosynthesis I 3 2 1
heptadecane biosynthesis 3 1 1
alkane biosynthesis I 3 1 1
fosfomycin biosynthesis 7 2 2
CDP-diacylglycerol biosynthesis II 4 4 1
CDP-diacylglycerol biosynthesis I 4 4 1
superpathway of phospholipid biosynthesis III (E. coli) 12 10 3
4-hydroxy-2-nonenal detoxification 4 1 1
L-tyrosine degradation I 5 5 1
phosphatidate biosynthesis (yeast) 5 3 1
CDP-diacylglycerol biosynthesis III 5 3 1
pentachlorophenol degradation 10 5 2
leucodelphinidin biosynthesis 5 1 1
5-nitroanthranilate degradation 6 3 1
superpathway of stearidonate biosynthesis (cyanobacteria) 6 2 1
palmitoyl ethanolamide biosynthesis 6 2 1
rhizocticin A and B biosynthesis 12 2 2
superpathway of cardiolipin biosynthesis (bacteria) 13 9 2
dehydrophos biosynthesis 13 2 2
diacylglycerol and triacylglycerol biosynthesis 7 3 1
stigma estolide biosynthesis 7 2 1
glutathione-mediated detoxification I 8 3 1
anandamide biosynthesis II 8 2 1
gliotoxin biosynthesis 9 2 1
glutathione-mediated detoxification II 9 1 1
superpathway of phospholipid biosynthesis II (plants) 28 10 3
3-phenylpropanoate degradation 10 6 1
FR-900098 and FR-33289 antibiotics biosynthesis 10 1 1
mycobactin biosynthesis 11 2 1
indole glucosinolate activation (intact plant cell) 12 3 1
anandamide biosynthesis I 12 3 1
camalexin biosynthesis 12 2 1
phosphinothricin tripeptide biosynthesis 25 4 2
phosalacine biosynthesis 25 4 2
hopanoid biosynthesis (bacteria) 14 4 1
plasmalogen biosynthesis I (aerobic) 16 3 1
type I lipoteichoic acid biosynthesis (S. aureus) 17 5 1